DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ: DMAA · FINANCIAL SERVICES · SHELL COMPANIES
$10.53
-0.28% today
Updated 2026-04-30
Market cap
$355.55M
P/E ratio
55.50
P/S ratio
—
EPS (TTM)
$0.19
Dividend yield
—
52W range
$10 – $11
Volume
0.2M
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 5
Last 5 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+121.0%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-0.1%
2025-09-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $0.01 | — | $10.37 | $10.38 | +0.1% |
| 2025-09-30 | $0.07 | — | $10.27 | $10.26 | -0.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $0.01 | — | — | — |
| 2025-09-30 | — | $0.07 | — | — | — |
| 2025-06-30 | — | $0.07 | — | — | — |
| 2025-03-31 | — | $0.05 | — | — | — |
| 2024-12-31 | $0.00 | $-0.03 | — | — | — |
Frequently asked questions
Has Drugs Made In America Acquisition Corp. Ordinary Shares beaten earnings estimates?
Drugs Made In America Acquisition Corp. Ordinary Shares has beaten Wall Street EPS estimates in 0 of its last 5 quarterly reports.
How does DMAA stock react to earnings?
DMAA stock has moved an average of -0.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.